522 related articles for article (PubMed ID: 36926345)
1. Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy.
Gu X; Liu Y; Dai X; Yang YG; Zhang X
Front Immunol; 2023; 14():1137107. PubMed ID: 36926345
[TBL] [Abstract][Full Text] [Related]
2. The new era of lung cancer therapy: Combining immunotherapy with ferroptosis.
Li Y; Tuerxun H; Zhao Y; Liu X; Li X; Wen S; Zhao Y
Crit Rev Oncol Hematol; 2024 Jun; 198():104359. PubMed ID: 38615871
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity.
Shi L; Liu Y; Li M; Luo Z
FEBS J; 2022 Jul; 289(13):3655-3665. PubMed ID: 34042258
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications.
Zhai X; Lin Y; Zhu L; Wang Y; Zhang J; Liu J; Li L; Lu X
Cytokine Growth Factor Rev; 2024 Feb; 75():101-109. PubMed ID: 37658030
[TBL] [Abstract][Full Text] [Related]
5. Programmed Cell Death Tunes Tumor Immunity.
Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
Front Immunol; 2022; 13():847345. PubMed ID: 35432318
[TBL] [Abstract][Full Text] [Related]
6. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
7. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and Cancer Immunotherapy.
Yin J; Meng X; Peng L; Xie W; Liu X; He W; Li S
Curr Mol Med; 2023; 23(5):401-409. PubMed ID: 35579155
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.
Niu X; Chen L; Li Y; Hu Z; He F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):273-285. PubMed ID: 35288298
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.
Xu H; Ye D; Ren M; Zhang H; Bi F
Trends Mol Med; 2021 Sep; 27(9):856-867. PubMed ID: 34312075
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
[TBL] [Abstract][Full Text] [Related]
14. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
15. Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity.
Luo L; Wang H; Tian W; Zeng J; Huang Y; Luo H
Am J Cancer Res; 2021; 11(11):5508-5525. PubMed ID: 34873476
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.
Zhu W; Liu X; Yang L; He Q; Huang D; Tan X
Eur J Pharmacol; 2023 Dec; 961():176124. PubMed ID: 37925133
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.
Yin W; Chang J; Sun J; Zhang T; Zhao Y; Li Y; Dong H
J Mater Chem B; 2023 Feb; 11(6):1171-1190. PubMed ID: 36650960
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance.
Cai J; Xu X; Saw PE
Sci China Life Sci; 2024 Jan; 67(1):19-40. PubMed ID: 37728804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]